Conference - Bethesda, MD, United States
Following year-on-year success, CHI presents the Sixth Annual Immunogenicity and Bioassay Summit 2014: 3 conferences, 45+ presentations, 15+ interactive breakout round table and panel discussions, exhibit/poster hall, and networking opportunities.Immunogenicity Prediction & Mitigation is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of bioassays and immunoassays and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements. Register today so you can join 250+ of your peers at the Number 1 Immunogenicity Summit in the U.S.
Organization: Cambridge Healthtech Institute (CHI)
For more information, visit: http://www.immunogenicitysummit.com
17–19 November 2014
Hyatt Regency Bethesda, One Bethesda Metro Center
Bethesda, MD, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.